DEFLAN 22,75 mg/ml gocce orali, sospensione
TREAT LMNA
Phase 2 small_molecule active
Quick answer
DEFLAN 22,75 mg/ml gocce orali, sospensione for Laminopathies is a Phase 2 program (small_molecule) at Sana Biotechnology with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sana Biotechnology
- Indication
- Laminopathies
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active